<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34935299</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-3279</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Brain and behavior</Title><ISOAbbreviation>Brain Behav</ISOAbbreviation></Journal><ArticleTitle>The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS).</ArticleTitle><Pagination><StartPage>e2465</StartPage><MedlinePgn>e2465</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2465</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.2465</ELocationID><Abstract><AbstractText Label="BACKGROUND">Targeting leptin could represent a rational strategy to treat amyotrophic lateral sclerosis (ALS), as previously clinical studies have shown its levels to be associated with a lower risk of ALS disease. However, very little is known about the potential influence of leptin in altering disease progression in ALS, as it has thus far been correlated with the protection exerted by increased fat mass stores.</AbstractText><AbstractText Label="METHODS">We studied the impact of leptin treatment beginning at 42-days of age (asymptomatic stage of disease) in the TDP-43 (TDP43<sup>A315T</sup> ) transgenic (Tg) ALS mouse model.</AbstractText><AbstractText Label="RESULTS">Our study shows that leptin treatment was associated with altered expression of adipokines and metabolic proteins in TDP43<sup>A315T</sup> mice. We also observed that weight loss decline was less prominent after leptin treatment in TDP43<sup>A315T</sup> mice relative to vehicle-treated animals. In TDP43<sup>A315T</sup> mice treated with leptin the disease duration lasted longer along with an improvement in motor performance relative to vehicle-treated animals.</AbstractText><AbstractText Label="CONCLUSIONS">Collectively, our results support leptin as a potential novel treatment approach for ALS.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferrer-Donato</LastName><ForeName>Agueda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurometabolism Research Lab., Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Salud (CEINSA), Universidad de Almer&#xed;a, Almer&#xed;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Paloma</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Applied Molecular Medicine (IMMA), Faculty of Medicine, Universidad San Pablo CEU, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Martos</LastName><ForeName>Carmen M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-6387-4456</Identifier><AffiliationInfo><Affiliation>Neurometabolism Research Lab., Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Hobart, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav</MedlineTA><NlmUniqueID>101570837</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020738">Leptin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020738" MajorTopicYN="N">Leptin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TAR DNA binding protein (TDP-43)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>7</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34935299</ArticleId><ArticleId IdType="pmc">PMC8785645</ArticleId><ArticleId IdType="doi">10.1002/brb3.2465</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed, R. M. , Phan, K. , Highton&#x2010;Williamson, E. , Strikwerda&#x2010;Brown, C. , Caga, J. , Ramsey, E. , &amp; Kiernan, M. C. (2019). Eating peptides: Biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia. Annals of Clinical and Translational Neurology, 6(3), 486&#x2013;495. 10.1002/acn3.721</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.721</ArticleId><ArticleId IdType="pmc">PMC6414477</ArticleId><ArticleId IdType="pubmed">30911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, J. J. , Ahsan, F. , Meezan, E. , &amp; Pillion, D. J. (2004). Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells. Journal of Pharmaceutical Sciences, 93(9), 2205&#x2013;2213. 10.1002/jps.20123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jps.20123</ArticleId><ArticleId IdType="pubmed">15295781</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahor, Z. , Liao, J. , Macleod, M. R. , Bannach&#x2010;Brown, A. , McCann, S. K. , Wever, K. E. , &amp; Sena, E. (2017). Risk of bias reporting in the recent animal focal cerebral ischaemia literature. Clinical Science (London, England: 1979), 131(20), 2525&#x2013;2532. 10.1042/CS20160722</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20160722</ArticleId><ArticleId IdType="pmc">PMC5869854</ArticleId><ArticleId IdType="pubmed">29026002</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcelo, M. A. , Povedano, M. , Vazquez&#x2010;Costa, J. F. , Franquet, A. , Solans, M. , &amp; Saez, M. (2021). Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia. Scientific Reports, 11(1), 6207. 10.1038/s41598-021-85395-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85395-z</ArticleId><ArticleId IdType="pmc">PMC7973725</ArticleId><ArticleId IdType="pubmed">33737526</ArticleId></ArticleIdList></Reference><Reference><Citation>Begley, C. G. , &amp; Ellis, L. M. (2012). Drug development: Raise standards for preclinical cancer research. Nature, 483(7391), 531&#x2013;533. 10.1038/483531a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/483531a</ArticleId><ArticleId IdType="pubmed">22460880</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco, H. , Lanznaster, D. , Veyrat&#x2010;Durebex, C. , Hergesheimer, R. , Vourch, P. , Maillot, F. , &amp; Corcia, P. (2020). Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics, 20(9), 907&#x2013;919. 10.1080/14737175.2020.1788389</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1788389</ArticleId><ArticleId IdType="pubmed">32583696</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup, C. , Desport, J. C. , Clavelou, P. , Guy, N. , Derumeaux&#x2010;Burel, H. , Ferrier, A. , &amp; Couratier, P. (2009). Hypermetabolism in ALS patients: An early and persistent phenomenon. Journal of Neurology, 256(8), 1236&#x2013;1242. 10.1007/s00415-009-5100-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen&#x2010;Plotkin, A. S. , Lee, V. M. , &amp; Trojanowski, J. Q. (2010). TAR DNA&#x2010;binding protein 43 in neurodegenerative disease. Nature Reviews Neurology, 6(4), 211&#x2013;220. 10.1038/nrneurol.2010.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.18</ArticleId><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang, T. N. , Lim, N. K. , Grubman, A. , Li, Q. X. , Volitakis, I. , White, A. R. , &amp; Crouch, P. J. (2014). Increased metal content in the TDP&#x2010;43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Frontiers in Aging Neuroscience, 6, 15. 10.3389/fnagi.2014.00015</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00015</ArticleId><ArticleId IdType="pmc">PMC3920072</ArticleId><ArticleId IdType="pubmed">24575040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis, E. , Siokas, V. , Sokratous, M. , Tsouris, Z. , Aloizou, A. M. , Florou, D. , &amp; Brotis, A. G. (2018). Body mass index and survival from amyotrophic lateral sclerosis: A meta&#x2010;analysis. Neurology Clinicial Practice, 8(5), 437&#x2013;444. 10.1212/CPJ.0000000000000521</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000521</ArticleId><ArticleId IdType="pmc">PMC6276330</ArticleId><ArticleId IdType="pubmed">30564498</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport, J. C. , Preux, P. M. , Magy, L. , Boirie, Y. , Vallat, J. M. , Beaufrere, B. , &amp; Couratier, P. (2001). Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. American Journal of Clinical Nutrition, 74(3), 328&#x2013;334. 10.1093/ajcn/74.3.328</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, L. , Oudart, H. , Rene, F. , Gonzalez de Aguilar, J. L. , &amp; Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high&#x2010;energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101(30), 11159&#x2013;11164. 10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott, R. M. , Morgan, L. M. , Tredger, J. A. , Deacon, S. , Wright, J. , &amp; Marks, V. (1993). Glucagon&#x2010;like peptide&#x2010;1 (7&#x2010;36)amide and glucose&#x2010;dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: Acute post&#x2010;prandial and 24&#x2010;h secretion patterns. Journal of Endocrinology, 138(1), 159&#x2013;166. 10.1677/joe.0.1380159</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/joe.0.1380159</ArticleId><ArticleId IdType="pubmed">7852887</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili, M. A. , Panahi, M. , Yadav, S. , Hennings, L. , &amp; Kiaei, M. (2013). Premature death of TDP&#x2010;43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. International Journal of Experimental Pathology, 94(1), 56&#x2013;64. 10.1111/iep.12006</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iep.12006</ArticleId><ArticleId IdType="pmc">PMC3575874</ArticleId><ArticleId IdType="pubmed">23317354</ArticleId></ArticleIdList></Reference><Reference><Citation>Farr, S. A. , Banks, W. A. , &amp; Morley, J. E. (2006). Effects of leptin on memory processing. Peptides, 27(6), 1420&#x2013;1425. 10.1016/S0196-9781(05)00475-4 [pii]10.1016/j.peptides.2005.10.006. 10.1016/j.peptides.2005.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-9781(05)00475-4</ArticleId><ArticleId IdType="doi">10.1016/j.peptides.2005.10.006</ArticleId><ArticleId IdType="pubmed">16293343</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez&#x2010;Martos, C. M. , Atkinson, R. A. K. , Chuah, M. I. , King, A. E. , &amp; Vickers, J. C. (2017). Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease. Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions, 3(1), 92&#x2013;106. 10.1016/j.trci.2016.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2016.11.002</ArticleId><ArticleId IdType="pmc">PMC5651376</ArticleId><ArticleId IdType="pubmed">29067321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer&#x2010;Donato, A. , Contreras, A. , Frago, L. M. , Chowen, J. A. , &amp; Fernandez&#x2010;Martos, C. M. (2021). Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS). International Journal of Molecular Sciences, 22(19), 10305. 10.3390/ijms221910305</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910305</ArticleId><ArticleId IdType="pmc">PMC8508891</ArticleId><ArticleId IdType="pubmed">34638645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri, A. , &amp; Coccurello, R. (2017). What is &#x201c;Hyper&#x201d; in the ALS Hypermetabolism? Mediators of Inflammation, 2017, 7821672. 10.1155/2017/7821672</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliedner, S. , Schulz, C. , &amp; Lehnert, H. (2006). Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology, 147(5), 2088&#x2013;2094. 10.1210/en.2005-1016 [pii]10.1210/en.2005&#x2010;1016. 10.1210/en.2005-1016</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2005-1016</ArticleId><ArticleId IdType="doi">10.1210/en.2005-1016</ArticleId><ArticleId IdType="pubmed">16469809</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman, J. M. (2011). Leptin and the regulation of body weight. Keio Journal of Medicine, 60(1), 1&#x2013;9. 10.2302/kjm.60.1</Citation><ArticleIdList><ArticleId IdType="doi">10.2302/kjm.60.1</ArticleId><ArticleId IdType="pubmed">21460597</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman, J. M. , &amp; Halaas, J. L. (1998). Leptin and the regulation of body weight in mammals. Nature, 395(6704), 763&#x2013;770. 10.1038/27376</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/27376</ArticleId><ArticleId IdType="pubmed">9796811</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacobbo, B. L. , Mediavilla, T. , Marcellino, D. J. , &amp; Sultan, F. (2021). Metabolic changes in an animal model of amyotrophic lateral sclerosis evaluated by [(18)F]&#x2010;FDG positron emission tomography. Translational Neurodegeneration, 10(1), 21. 10.1186/s40035-021-00246-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00246-1</ArticleId><ArticleId IdType="pmc">PMC8220836</ArticleId><ArticleId IdType="pubmed">34162436</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Y. , Wang, Q. , Zhang, K. , An, T. , Shi, P. , Li, Z. , &amp; Li, C. (2012). HO&#x2010;1 induction in motor cortex and intestinal dysfunction in TDP&#x2010;43 A315T transgenic mice. Brain Research, 1460, 88&#x2013;95. 10.1016/j.brainres.2012.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.04.003</ArticleId><ArticleId IdType="pubmed">22578468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros, T. , Bogdanik, L. P. , Tassinari, V. R. , Kidd, J. D. , Moreno, A. J. , Davis, C. , &amp; Perrin, S. (2014). C57BL/6J congenic Prp&#x2010;TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Research, 1584, 59&#x2013;72. 10.1016/j.brainres.2013.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.10.013</ArticleId><ArticleId IdType="pubmed">24141148</ArticleId></ArticleIdList></Reference><Reference><Citation>Holst, J. J. , &amp; Rosenkilde, M. M. (2020). Recent advances of GIP and future horizons. Peptides, 125, 170230. 10.1016/j.peptides.2019.170230</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2019.170230</ArticleId><ArticleId IdType="pubmed">31838219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides, Z. A. , Ngo, S. T. , Henderson, R. D. , McCombe, P. A. , &amp; Steyn, F. J. (2016). Altered metabolic homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of energy imbalance and contribution to disease progression. Neurodegenerative Diseases, 16(5&#x2010;6), 382&#x2013;397. 10.1159/000446502</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446502</ArticleId><ArticleId IdType="pubmed">27400276</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid, A. , Gapp, K. , &amp; Schulz, P. E. (2014). Mitochondrial dysfunction and decrease in body weight of transgenic knock&#x2010;in mouse model for TDP&#x2010;43: The question of glucose? Journal of Biological Chemistry, 289(26), 18593. 10.1074/jbc.L114.572651</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.L114.572651</ArticleId><ArticleId IdType="pmc">PMC4140249</ArticleId><ArticleId IdType="pubmed">24973427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn, S. E. , Zinman, B. , Haffner, S. M. , O'Neill, M. C. , Kravitz, B. G. , Yu, D. , &amp; Group, A. S. (2006). Obesity is a major determinant of the association of C&#x2010;reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes, 55(8), 2357&#x2013;2364. 10.2337/db06-0116</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db06-0116</ArticleId><ArticleId IdType="pubmed">16873701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuraszkiewicz, B. , Goszczynska, H. , Podsiadly&#x2010;Marczykowska, T. , Piotrkiewicz, M. , Andersen, P. , Gromicho, M. , &amp; de Carvalho, M. (2020). Potential preventive strategies for amyotrophic lateral sclerosis. Frontiers in Neuroscience, 14, 428. 10.3389/fnins.2020.00428</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00428</ArticleId><ArticleId IdType="pmc">PMC7264408</ArticleId><ArticleId IdType="pubmed">32528241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, I. , Kazamel, M. , McPherson, T. , McAdam, J. , Bamman, M. , Amara, A. , &amp; King, P. H. (2021). Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual&#x2010;energy x&#x2010;ray absorptiometry in a prospective study. PLoS ONE, 16(5), e0251087. 10.1371/journal.pone.0251087</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251087</ArticleId><ArticleId IdType="pmc">PMC8101939</ArticleId><ArticleId IdType="pubmed">33956876</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, M. A. , Bence, K. K. , Sandesara, I. , Andreux, P. , Auwerx, J. , Ishibashi, J. , Seale, P. , &amp; Kalb, R. G. (2014). Genetically altering organismal metabolism by leptin&#x2010;deficiency benefits a mouse model of amyotrophic lateral sclerosis. Human Molecular Genetics, 23(18), 4995&#x2013;5008. 10.1093/hmg/ddu214</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu214</ArticleId><ArticleId IdType="pmc">PMC4140473</ArticleId><ArticleId IdType="pubmed">24833719</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. , Hanson, K. A. , McCormack, G. , Atkinson, R. A. K. , Dittmann, J. , Vickers, J. C. , &amp; King, A. E. (2020). Enhanced anti&#x2010;amyloid effect of combined leptin and pioglitazone in APP/PS1 transgenic mice. Current Alzheimer Research, 17(14), 1294&#x2013;1301. 10.2174/1567205018666210218163857</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205018666210218163857</ArticleId><ArticleId IdType="pubmed">33602093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Gomez, J. J. , Ballesteros&#x2010;Pomar, M. D. , Torres&#x2010;Torres, B. , De la Maza, B. P. , Penacho&#x2010;Lazaro, M. A. , Palacio&#x2010;Mures, J. M. , &amp; De Luis&#x2010;Roman, D. A. (2021). Malnutrition at diagnosis in amyotrophic lateral sclerosis (ALS) and its influence on survival: Using glim criteria. Clinical Nutrition, 40(1), 237&#x2013;244. 10.1016/j.clnu.2020.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.05.014</ArticleId><ArticleId IdType="pubmed">32507583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph, A. C. , Dorst, J. , Dreyhaupt, J. , Weishaupt, J. H. , Kassubek, J. , Weiland, U. , &amp; Group, L.&#x2010;A. S. (2020). Effect of high&#x2010;caloric nutrition on survival in amyotrophic lateral sclerosis. Annals of Neurology, 87(2), 206&#x2013;216. 10.1002/ana.25661</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandillo, S. , Tucci, V. , Holter, S. M. , Meziane, H. , Banchaabouchi, M. A. , Kallnik, M. , &amp; Wurst, W. (2008). Reliability, robustness, and reproducibility in mouse behavioral phenotyping: A cross&#x2010;laboratory study. Physiological Genomics, 34(3), 243&#x2013;255. 10.1152/physiolgenomics.90207.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.90207.2008</ArticleId><ArticleId IdType="pmc">PMC2519962</ArticleId><ArticleId IdType="pubmed">18505770</ArticleId></ArticleIdList></Reference><Reference><Citation>Marwarha, G. , Dasari, B. , Prasanthi, J. R. , Schommer, J. , &amp; Ghribi, O. (2010). Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27&#x2010;hydroxycholesterol in rabbit organotypic slices. Journal of Alzheimers Disease, 19(3), 1007&#x2013;1019. 10.3233/JAD-2010-1298</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1298</ArticleId><ArticleId IdType="pmc">PMC2924284</ArticleId><ArticleId IdType="pubmed">20157255</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina, D. X. , Orr, M. E. , &amp; Oddo, S. (2014). Accumulation of C&#x2010;terminal fragments of transactive response DNA&#x2010;binding protein 43 leads to synaptic loss and cognitive deficits in human TDP&#x2010;43 transgenic mice. Neurobiology of Aging, 35(1), 79&#x2013;87. 10.1016/j.neurobiolaging.2013.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.07.006</ArticleId><ArticleId IdType="pubmed">23954172</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel, G. , Peter, R. S. , Rosenbohm, A. , Koenig, W. , Dupuis, L. , Rothenbacher, D. , &amp; Ludolph, A. C. (2017). Adipokines, C&#x2010;reactive protein and Amyotrophic Lateral Sclerosis &#x2010; results from a population&#x2010; based ALS registry in Germany. Scientific Reports, 7(1), 4374. 10.1038/s41598-017-04706-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04706-5</ArticleId><ArticleId IdType="pmc">PMC5491500</ArticleId><ArticleId IdType="pubmed">28663573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo, S. T. , Steyn, F. J. , Huang, L. , Mantovani, S. , Pfluger, C. M. , Woodruff, T. M. , &amp; McCombe, P. A. (2015). Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 357(1&#x2010;2), 22&#x2013;27. 10.1016/j.jns.2015.06.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.053</ArticleId><ArticleId IdType="pubmed">26198021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega Moreno, L. , Sanz&#x2010;Garcia, A. , Fernandez de la Fuente, M. J. , Arroyo Solera, R. , Fernandez&#x2010;Tome, S. , Marin, A. C. , &amp; Bernardo, D. (2020). Serum adipokines as non&#x2010;invasive biomarkers in Crohn's disease. Scientific Reports, 10(1), 18027. 10.1038/s41598-020-74999-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74999-6</ArticleId><ArticleId IdType="pmc">PMC7582883</ArticleId><ArticleId IdType="pubmed">33093517</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni, S. , Deng, J. , Jaffa, M. , Cudkowicz, M. E. , &amp; Wills, A. M. (2011). Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle &amp; Nerve, 44(1), 20&#x2013;24. 10.1002/mus.22114</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape, J. A. , &amp; Grose, J. H. (2020). The effects of diet and sex in amyotrophic lateral sclerosis. Revue Neurologique, 176(5), 301&#x2013;315. 10.1016/j.neurol.2019.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher&#x2010;Martel, V. , Boutej, H. , Cordeau, P. , Kaneb, H. , Julien, J. &#x2010; P. , Genge, A. , &amp; Kriz, J. (2021). Changes in Leptin, CCL16 and sTNF&#x2010;RII as a Distinctive Plasma Immune Profile in Patients with Fast Progressing ALS (1276). Neurology, 96(15 Supplement), (1276).</Citation></Reference><Reference><Citation>Rahnemayan, S. , Mirghafourvand, M. , Fathalizadeh, A. , Faramarzi, E. , Reyhanifard, A. , Mahmoodpoor, A. , &amp; Sanaie, S. (2021). Leptin levels in patients with Parkinson's disease: A systematic review and meta&#x2010;analysis. Clinical Nutrition ESPEN, 41, 104&#x2013;109. 10.1016/j.clnesp.2020.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2020.11.001</ArticleId><ArticleId IdType="pubmed">33487251</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez, A. , Ferrer&#x2010;Donato, A. , Cabrera&#x2010;Pinto, M. , Sese&#xf1;a, S. , Fern&#xe1;ndez, P. , Aranda, A. , &amp; Fernandez&#x2010;Martos, C. M. (2021). Effect of ozone exposure on amyotrophic lateral sclerosis (ALS) pathology using a mice model of TDP&#x2010;43 proteinopathy. bioRxiv, 2021.2002.2012.430915. 10.1101/2021.02.12.430915 bioRxiv</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.12.430915</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, T. , Hanyu, H. , Hirao, K. , Kanetaka, H. , Sakurai, H. , &amp; Iwamoto, T. (2011). Efficacy of PPAR&#x2010;gamma agonist pioglitazone in mild Alzheimer disease. Neurobiology of Aging, 32(9), 1626&#x2013;1633. 10.1016/j.neurobiolaging.2009.10.009S0197-4580(09)00339-X [pii].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.10.009S0197-4580(09)00339-X</ArticleId><ArticleId IdType="pubmed">19923038</ArticleId></ArticleIdList></Reference><Reference><Citation>Searcy, J. L. , Phelps, J. T. , Pancani, T. , Kadish, I. , Popovic, J. , Anderson, K. L. , &amp; Thibault, O. (2012). Long&#x2010;term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease. Journal of Alzheimers Disease, 30(4), 943&#x2013;961. 10.3233/JAD-2012-11166107T40865VP760877 [pii].</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-11166107T40865VP760877</ArticleId><ArticleId IdType="pmc">PMC3378773</ArticleId><ArticleId IdType="pubmed">22495349</ArticleId></ArticleIdList></Reference><Reference><Citation>Seino, Y. , Fukushima, M. , &amp; Yabe, D. (2010). GIP and GLP&#x2010;1, the two incretin hormones: Similarities and differences. Journal of Diabetes Investigation, 1(1&#x2010;2), 8&#x2013;23. 10.1111/j.2040-1124.2010.00022.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2040-1124.2010.00022.x</ArticleId><ArticleId IdType="pmc">PMC4020673</ArticleId><ArticleId IdType="pubmed">24843404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan, X. , Chiang, P. M. , Price, D. L. , &amp; Wong, P. C. (2010). Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP&#x2010;43 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 107(37), 16325&#x2013;16330. 10.1073/pnas.1003459107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003459107</ArticleId><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, P. , Peterson, T. E. , Barber, K. R. , Kuniyoshi, F. S. , Jensen, A. , Hoffmann, M. , &amp; Somers, V. K. (2010). Leptin upregulates the expression of plasminogen activator inhibitor&#x2010;1 in human vascular endothelial cells. Biochemical and Biophysical Research Communications, 392(1), 47&#x2013;52. 10.1016/j.bbrc.2009.12.158</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.12.158</ArticleId><ArticleId IdType="pmc">PMC2831408</ArticleId><ArticleId IdType="pubmed">20051227</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallings, N. R. , Puttaparthi, K. , Luther, C. M. , Burns, D. K. , &amp; Elliott, J. L. (2010). Progressive motor weakness in transgenic mice expressing human TDP&#x2010;43. Neurobiology of Disease, 40(2), 404&#x2013;414. 10.1016/j.nbd.2010.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.06.017</ArticleId><ArticleId IdType="pubmed">20621187</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens, T. W. , Basinski, M. , Bristow, P. K. , Bue&#x2010;Valleskey, J. M. , Burgett, S. G. , Craft, L. , Hale, J. , Hoffmann, J. , Hsiung, H. M. , Kriauciunas, A. , MacKellar, W. , Rosteck, P. R. Jr. , Schoner, B. , Smith, D. , Tinsley, F. C. , Zhang, X.&#x2010;Y. , &amp; Heiman, M. (1995). The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377(6549), 530&#x2013;532. 10.1038/377530a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/377530a0</ArticleId><ArticleId IdType="pubmed">7566151</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia, R. (2014). Cellular and molecular mechanisms of motor neuron death in amyotrophic lateral sclerosis: A perspective. Frontiers in Cellular Neuroscience, 8, 241. 10.3389/fncel.2014.00241</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00241</ArticleId><ArticleId IdType="pmc">PMC4132292</ArticleId><ArticleId IdType="pubmed">25177274</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera, T. W. , &amp; Borges, K. (2016). Metabolic dysfunctions in Amyotrophic Lateral Sclerosis pathogenesis and potential metabolic treatments. Frontiers in Neuroscience, 10, 611. 10.3389/fnins.2016.00611</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera, T. W. , Steyn, F. J. , Ngo, S. T. , &amp; Borges, K. (2021). CNS glucose metabolism in Amyotrophic Lateral Sclerosis: A therapeutic target? Cell &amp; Bioscience, 11(1), 14. 10.1186/s13578-020-00511-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne, T. , De Bock, K. , &amp; Van Den Bosch, L. (2018). Energy metabolism in ALS: An underappreciated opportunity? Acta Neuropathologica, 135(4), 489&#x2013;509. 10.1007/s00401-018-1835-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W. , Li, L. , Lin, W. L. , Dickson, D. W. , Petrucelli, L. , Zhang, T. , &amp; Wang, X. (2013). The ALS disease&#x2010;associated mutant TDP&#x2010;43 impairs mitochondrial dynamics and function in motor neurons. Human Molecular Genetics, 22(23), 4706&#x2013;4719. 10.1093/hmg/ddt319</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska, I. , Bell, S. , Cairns, N. J. , Miller, T. M. , &amp; Baloh, R. H. (2009). TDP&#x2010;43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proceedings of the National Academy of Sciences of the United States of America, 106(44), 18809&#x2013;18814. 10.1073/pnas.0908767106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei, S. , Carr, K. , Reiley, L. , Diaz, K. , Guerra, O. , Altamirano, P. F. , &amp; Chinea, A. (2015). A comprehensive review of amyotrophic lateral sclerosis. Surgical Neurology International, 6, 171. 10.4103/2152-7806.169561</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. , &amp; Chua, S. Jr. (2017). Leptin function and regulation. Comprehensive Physiology, 8(1), 351&#x2013;369. 10.1002/cphy.c160041</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c160041</ArticleId><ArticleId IdType="pubmed">29357132</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. , Proenca, R. , Maffei, M. , Barone, M. , Leopold, L. , &amp; Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372(6505), 425&#x2013;432. 10.1038/372425a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/372425a0</ArticleId><ArticleId IdType="pubmed">7984236</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou, X. , Zhong, L. , Zhu, C. , Zhao, H. , Zhao, F. , Cui, R. , &amp; Li, B. (2019). Role of leptin in mood disorder and neurodegenerative disease. Frontiers in Neuroscience, 13, 378. 10.3389/fnins.2019.00378</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00378</ArticleId><ArticleId IdType="pmc">PMC6510114</ArticleId><ArticleId IdType="pubmed">31130833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>